Reliability and Validity of DIDA-Q in Parkinson's Disease

March 11, 2025 updated by: Marmara University

Validity and Reliability of the Dual Task Impact on Daily Living Questionnaire in Patients with Parkinson's Disease

The aim of our study is to investigate the validity and reliability of the Dual Task Impact on Daily-living Activities (DIDA-Q) to assess the degree of difficulty felt when performing dual tasks during activities of daily living in patients with Parkinson's disease. In our study, the validity and reliability of a questionnaire to assess the degree of difficulty felt while performing dual tasks during activities of daily living in Parkinson's Disease will be examined for the first time. The study will include 95 participants with Hoehn-Yahr Stage 1-3, diagnosed with Idiopathic Parkinson's Disease and able to walk 10 metres without an assistive device.

Study Overview

Detailed Description

Dual task ability is defined as the ability to perform two activities simultaneously . It is known that the ability to perform a motor or cognitive secondary activity at the same time during walking (talking to a person next to you while walking or carrying objects while walking) leads to gait and balance problems of different severity depending on the type of secondary task in Parkinson's Disease (PD). When patients with Parkinson's Disease (pwPD) are exposed to dual-task walking, their walking speed and length of stride decrease, and the frequency of freezing phenomena during walking increases. Consequently the risk of falling increase during activities of daily living. Individuals often perform dual tasks while performing activities of daily living because of the nature of the tasks' requirements. Therefore, it has become important to evaluate dual task performance in order to create the right treatment plan in the field of neurological physiotherapy and rehabilitation. Although dual task performance is evaluated with different formulae in the literature, the number of scales evaluating the level of difficulty perceived by the patient during the performance of activities of daily living under dual task is limited. The validity of the existing scales for PD has not been studied. The Dual-task Impact on Daily-living Activities Questionnaire (DIDA-Q) is a patient-reported questionnaire developed to assess the degree of difficulty perceived when performing dual tasks during activities of daily living.

Study Type

Observational

Enrollment (Actual)

95

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Çapa
      • Istanbul, Çapa, Turkey
        • Istanbul University, Faculty of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients who diagnosed with Parkinson's disease were included.

Description

Inclusion Criteria:

  • Diagnosed with Idiopathic Parkinson's Disease according to UK Brain Bank criteria
  • Walking at least 10 metres without an assistive device
  • To have the cognitive capability to understand and answer the questions asked in the scale

Exclusion Criteria:

  • Having any neurological disease other than idiopathic Parkinson's Disease
  • The person has an orthopaedic or cardiopulmonary disease that affects walking
  • Severe hearing-visual impairment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
DIDA-Q
Time Frame: 1 week
Dual Task Impact on Daily-living Activities Questionnaire, higher scores means bad dual task performance
1 week

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Six Spot Step Test cognitive
Time Frame: 1 week
Designed to assess motor-cognitive dual task performance.
1 week
Dual Task Interference
Time Frame: 1 week
It is calculating with a formula which contain single and dual task performance.
1 week
Dual Task Questionnaire
Time Frame: 1 week
patient-reported questionnaire used to measure dual-task performance
1 week
Parkinson Activity Scale
Time Frame: 1 week
a scale to assess patients' mobility and transfers
1 week
Mini-Mental State Examination
Time Frame: 1 week
a short questionnaire giving information about the cognitive status of the patients
1 week
Freezing of Gait Questionnaire
Time Frame: 1 week
a scale questioning the frequency of freezing and freezing qualities in walking
1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 13, 2024

Primary Completion (Actual)

January 1, 2025

Study Completion (Actual)

January 10, 2025

Study Registration Dates

First Submitted

January 13, 2025

First Submitted That Met QC Criteria

March 11, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 11, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on Dual Task Impact on Daily-living Activities Questionnaire

Subscribe